Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma Article

Singh, Kirit, Batich, Kristen A, Wen, Patrick Y et al. (2022). Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma . CLINICAL CANCER RESEARCH, 28(4), 585-593. 10.1158/1078-0432.CCR-21-2681

Open Access International Collaboration

cited authors

  • Singh, Kirit; Batich, Kristen A; Wen, Patrick Y; Tan, Aaron C; Bagley, Stephen J; Lim, Michael; Platten, Michael; Colman, Howard; Ashley, David M; Chang, Susan M; Rahman, Rifaquat; Galanis, Evanthia; Mansouri, Alireza; Puduvalli, Vinay K; Reardon, David A; Sahebjam, Solmaz; Sampson, John H; Simes, John; Berry, Donald A; Zadeh, Gelareh; Cloughesy, Tim F; Mehta, Minesh P; Piantadosi, Steven; Weller, Michael; Heimberger, Amy B; Khasraw, Mustafa

sustainable development goals

authors

publication date

  • February 15, 2022

published in

keywords

  • CHIMERIC ANTIGEN RECEPTOR
  • EFFICACY
  • Life Sciences & Biomedicine
  • MAINTENANCE
  • MECHANISMS
  • NEUROONCOLOGY
  • Oncology
  • RADIOTHERAPY
  • RESPONSE ASSESSMENT
  • SURVIVAL
  • Science & Technology
  • T-CELLS
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 585

end page

  • 593

volume

  • 28

issue

  • 4